CLASS II Drug recall · Reported 7 May 2014 · FDA Enforcement Report

Lupron Depot-ped (Leuprolide Acetate recalled by AbbVie

AbbVie is recalling Lupron Depot-ped (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit, distributed nationwide in the US. The recall was initiated on 10 Mar 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #:1013566, Exp 12/08/16
NDC0074-2108, 0074-2282, 0074-2440, 0074-3779, 0074-9694, 0074-3575
UPC300743779035
Quantity recalled12 kits

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1289-2014
FDA event ID
67709
Recalling firm
AbbVie, North Chicago, IL
Manufacturer
AbbVie Inc.
Classification
Class II
Status
Terminated
Recall initiated
10 Mar 2014
FDA classified
29 Apr 2014
Reported
7 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Mar 2014Recall initiated by company
29 Apr 2014Classified by FDA+50 days
7 May 2014Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Product as listed by the FDA

LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5.

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Is Lupron Depot-ped (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit recalled?

Yes. AbbVie recalled Lupron Depot-ped (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit on 10 Mar 2014. The recall is Class II and its status is Terminated. Recall number D-1289-2014.

Why was it recalled?

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Which lots are affected?

Lot #:1013566, Exp 12/08/16

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AbbVie

All 20

Other Leuprolide recalls

All 6
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIEligard (leuprolide acetate) for injectable suspension recalledEligardTolmarSterilityNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot (leuprolide acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide
DrugCLASS IILupron Depot (Leuprolide Acetate recalled by AbbVieLupron DepotAbbVieOtherNationwide